Investor Alert

London Markets Open in:

Revolution Medicines Inc.



After Hours

 --Quotes are delayed by 20 min

Oct 4, 2022, 4:02 p.m.





0.00 0.00%


Volume 169,529

Quotes are delayed by 20 min


Previous close

$ 19.53

$ 20.00


+0.47 +2.41%

Day low

Day high




52 week low

52 week high




Margaret A. Horn

Margaret A. Horn is Chief Operating Officer & General Counsel at Revolution Medicines, Inc. and Secretary & General Counsel for Genencor International, Inc. Dr. Horn is also Member of The State Bar of California and Member of Pennsylvania Bar Association.

Dr. Horn previously occupied the position of Chief Operating Officer at Prolynx LLC, SVP-Corporate Development & General Counsel at Cogentus Pharmaceuticals, Inc., Principal at E.I. du Pont de Nemours & Co. and General Counsel & Secretary at Kosan Biosciences, Inc.

Dr. Horn received a graduate degree from Charles Widger School of Law and an undergraduate degree from the University of the Sciences in Philadelphia.


Date Shares Transaction Value
06/17/2022 1,145   Disposition at $17.75 per share. 20,324
03/17/2022 321   Disposition at $18.61 per share. 5,974
03/01/2022 38,800   Award at $0 per share. 0
12/17/2021 491   Disposition at $24.41 per share. 11,986
09/17/2021 479   Disposition at $30.02 per share. 14,380
06/17/2021 464   Disposition at $34.13 per share. 15,837
03/04/2021 15,000   Award at $0 per share. 0
02/05/2021 35,000   Disposition at $55 per share. 1,925,000
02/05/2021 35,000   Derivative/Non-derivative trans. at $4.73 per share. 165,550
10/02/2020 12,495   Disposition at $35.4 per share. 442,323
10/01/2020 57,505   Disposition at $35.01 per share. 2,013,251

Officers and Executives

Dr. Mark A. Goldsmith
Chairman, President & Chief Executive Officer
Dr. Margaret A. Horn
Chief Operating Officer & General Counsel
Mr. Jack Anders
Chief Financial Officer
Dr. Stephen M. Kelsey
President-Research & Development
Dr. Walter Reiher
Chief Information Officer
Dr. Xiao Lin Wang
Executive Vice President-Clinical Development
Dr. Sushil Patel
Ms. Luan M. Wilfong
Senior Vice President-Human Resources
Mr. Jeff Cislini
Secretary, Senior Vice President & General Counsel
Dr. Eric Schmidt
Independent Director
Dr. Flavia Borellini
Independent Director
Dr. Lorence H. Kim
Independent Director
Ms. Elizabeth McKee Anderson
Independent Director
Mr. Alexis A. Borisy
Lead Independent Director
Dr. Thilo Schroeder
Independent Director
Dr. Barbara L. Weber
Independent Director
Link to MarketWatch's Slice.